Drug Database
AN

antofloxacin hydrochloride

✓ Approved

Anhui Globe Pharmaceutical · TOP2A · 小分子

什么是 antofloxacin hydrochloride?

antofloxacin hydrochloride 是一种小分子,由Anhui Globe Pharmaceutical研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intravenous (IV)、Oral (PO)。

药物档案

公司Anhui Globe Pharmaceutical
药物类别小分子
分子靶点TOP2A
给药途径Injectable (Others), Intravenous (IV), Oral (PO)
状态Approved

作用机制

分子靶点

antofloxacin hydrochloride 作用于 1 个分子靶点:

TOP2ADNA topoisomerase II alpha (TOP2alpha, TOPIIA)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

antofloxacin hydrochloride 针对 3 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsPneumonia✓ Approved
Infections and infestationsUrinary tract infection✓ Approved
Infections and infestationsStreptococcal infection✓ Approved

相关研究文献

PubMedFrontiers in aging2026-11-18

Effect of papaverine hydrochloride on functional visual acuity in non-arteritic central retinal artery occlusion: a retrospective cohort study.

Liu Zhongzhong Z, Lu Qingli Q, Liu Tong T, Peng Linna L et al.

Non-arteritic central retinal artery occlusion (NA-CRAO) is an acute ocular emergency that frequently results in severe and irreversible vision loss with limited therapeutic options. Papaverine hydrochloride, a non-specific vasodilator commonly used to relieve vasospasm, has not been previously evaluated for its potential benefits for visual recovery in patients with NA-CRAO. Therefore, this study aims to investigate the association between papaverine hydrochloride treatment (PHt) and functional visual acuity improvement in patients with NA-CRAO. Propensity-score matching was used to retrospectively collect clinical data of 104 NA-CRAO patients with similar baseline characteristics. The patients were categorized into a PHt group (n = 52) and a non-papaverine hydrochloride treatment (non-PHt) group (n = 52). The primary outcome was functional visual acuity (best-corrected visual acuity ≥20/100) assessed at discharge and at a 1-month follow-up. Logistic regression and subgroup analyses were performed to evaluate the associations between papaverine hydrochloride use and improvements in functional visual acuity. The PHt group showed significantly higher functional visual acuity than the non-PHt group at discharge (32.7% vs. 15.4%, p = 0.039) and at the 1-month follow-up (53.8% vs. 34.6%, p = 0.048). In adjusted models, treatment with papaverine hydrochloride was an independent favorable factor for improved functional visual acuity at discharge (odds ratio [OR] = 3.52, 95% confidence interval [CI]: 1.20-10.36, p = 0.022) and at the 1-month follow-up (OR = 3.15, 95% CI: 1.19-8.29, p = 0.020). Subgroup analyses demonstrated consistent therapeutic effects across age, sex, the side of the affected eye, intra-arterial thrombolysis and intravenous thrombolysis strata, with no statistically significant interaction effects identified at either time point (all Pinteraction >0.05). Treatment with papaverine hydrochloride was significantly associated with visual recovery in patients with NA-CRAO. Prospective further studies of causality are needed to validate these results and assess their safety.

PMID 43047374
阅读全文 →
PubMedVestnik otorinolaringologii2026-11-18

[Possibilities of topical therapy of acute bullous otitis media].

Baranov K K KK, Vyazmenov E O EO, Kotova E N EN, Polunin M M MM et al.

Bullous myringitis is a borderline condition between inflammatory processes of the external and middle ear. The aim was to evaluate the comparative efficacy of three combined topical preparations in complex treatment of acute bullous otitis media. 140 patients aged 6-40 years (110 (78.6%) children) were divided into three groups: group 1 (n=50) - chloramphenicol+clotrimazole+beclomethasone dipropionate+lidocaine hydrochloride; group 2 (n=45) - phenazone+lidocaine; group 3 (n=45) - neomycin+polymyxin B+dexamethasone. Pain relief was fastest in group 2 (by day 3); otoscopic signs resolved by day 5, with the best combined results in group 1. In 25-28 (17.9-20.0%) patients bullous otitis was associated with PCR-confirmed influenza A (H1N1); Mycoplasma pneumoniae was detected in 4 (2.9%). The incidence peaked in December-February.

PMID 43046736
阅读全文 →
PubMedFrontiers in neuroscience2026-11-18

De novo POLR2A p.(L1127F) variant presenting with neurodevelopmental regression and dystonia, with favorable response to low-dose dopamine therapy: a case report and literature review.

Cao Zhuci Z, Shen Qinru Q, Tangzhu Chenchen C, Guo Xiaohui X et al.

Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities (NEDHIB) is a rare autosomal-dominant condition caused by pathogenic POLR2A variants. It typically presents in infancy with hypotonia, developmental delay, and multisystem manifestations. Fewer than 40 patients have been reported worldwide, suggesting frequent misdiagnosis and underdiagnosis. To our knowledge, neurodevelopmental regression has not been documented in confirmed NEDHIB cases, and no standardized therapeutic regimens are established for clinical management. The patient presented with neonatal hypotonia and developmental delay. At 2 years and 4 months, she developed sleep-associated dystonia-like nodding and limb tremors that were initially suspected to represent epileptic seizures. By 3 years of age, she exhibited marked neurodevelopmental regression: loss of the ability to walk and sit independently, together with deterioration of language function. Electroencephalography (EEG) demonstrated background slowing accompanied by epileptiform discharges. Whole-exome sequencing identified a de novo heterozygous POLR2A variant c.3379C > T (p. L1127F), which confirmed the diagnosis of NEDHIB. Long-term rehabilitation training yielded only modest clinical benefits. After initiation of the dopamine agent levodopa-benserazide hydrochloride, marked improvements in motor and cognitive performance were observed, accompanied by the complete resolution of nodding episodes. With dose titration during follow-up, her clinical status remained stable without symptom relapse. This case expands the phenotypic spectrum associated with POLR2A-related NEDHIB and suggests that neurodevelopmental regression may occur within the phenotypic spectrum of this disorder. Our findings also highlight the potential benefit of low-dose dopamine therapy, offering novel insights into the clinical diagnosis, differential diagnosis, and therapeutic management of NEDHIB.

PMID 43047756
阅读全文 →
PubMedBMC pharmacology & toxicology2026-11-17

Bioequivalence of two formulations of amitriptyline hydrochloride tablets in healthy Chinese subjects under fasting and fed conditions.

Zhang Jingjing J, Zhai You Y, Kai Jiejing J, Wu Minglan M et al.

The study evaluated the bioequivalence and tolerability of a generic amitriptyline hydrochloride tablet compared to the reference product in healthy Chinese subjects under both fasting and postprandial conditions to support its marketing authorization. A single-center, open-label, randomized, single-dose, two-period, two-sequence crossover study was conducted. Eligible subjects took a single 25 mg dose of the generic or reference product per cycle in random order. Plasma drug concentrations were detected by LC-MS/MS and the bioequivalence of the two formulations was assessed through key pharmacokinetic parameters (Cmax, AUC0-t, and AUC0-∞) of amitriptyline. Adverse events were continuously monitored throughout the trial. The 90% confidence intervals (CIs) for the geometric mean ratios (GMRs) of Cmax, AUC0-t, and AUC0-∞ between the two products fell within the 80-125% range under both fasting and postprandial conditions. Our study indicated that food intake increases systemic exposure to amitriptyline without affecting Tmax. Both formulations were well tolerated, with predominantly mild adverse events and no severe or fatal events. The generic amitriptyline hydrochloride tablets by Changzhou Siyao Pharmaceuticals Co., Ltd. were bioequivalent to the reference formulation by Sandoz Inc. with comparable tolerability. This study was registered at www.chinadrugtrials.org.cn under the registration number CTR20212242 (November 2, 2021).

PMID 43040400
阅读全文 →
PubMedBiomedical chromatography : BMC2026-11-17

Quality Evaluation of Bazhen Yimu Tablets Based on HPLC Fingerprints and QAMS Method Combined With Chemometrics.

Yang Ting T, Wang Sheng S, Deng Xiaohong X, Jiang Xun X et al.

Bazhen Yimu tablets is a commonly used Chinese patent medicine. It has the functions of replenishing qi and nourishing blood, regulating menstruation and relieving pain. In this study, an HPLC method was employed to develop fingerprints for 15 batches of Bazhen Yimu tablets, followed by similarity evaluation. Chemical pattern recognition analysis was performed on different batches using cluster analysis (CA), principal component analysis (PCA), and orthogonal partial least squares-discriminant analysis (OPLS-DA). Concurrently, a QAMS method was established using paeoniflorin as the internal reference substance to determine the relative correction factors between the internal reference and atractylenolide III, leonurine hydrochloride, benzoylpaeoniflorin, 1,2,3,4,6-pentagalloylglucose, glycyrrhizic acid, senkyunolide A, chlorogenic acid, ferulic acid, 3-butylidenephthalide, and Z-ligustilide. The contents of 11 components in Bazhen Yimu tablets were determined separately using both the external standard method (ESM) and the QAMS method to verify the reliability of the QAMS results. The HPLC fingerprint and QAMS method developed in this study demonstrate good reproducibility and operational simplicity, and can provide a reference for the quality control and comprehensive evaluation of Bazhen Yimu tablets.

PMID 43041115
阅读全文 →
PubMedJournal of forensic sciences2026-11-17

Screening of residual solvents in cocaine seizures by HS-SPME-GC-MS: Application to multi-class solvent profiling.

Góngora Juan J

A headspace solid-phase microextraction coupled to gas chromatography-mass spectrometry (HS-SPME-GC-MS) method was developed for the screening of 50 residual solvents (RS), including alcohols, ethers, esters, ketones, aliphatics, aromatics, and chlorinated solvents. Given the chemical diversity of the compounds, a diluent selection step was critically addressed to ensure analyte compatibility. Some key GC parameters were optimized using a one-variable-at-a-time (OVAT) approach, whereas HS-SPME extraction parameters (extraction time, temperature, desorption time) were optimized using a design of experiments (DoE) strategy. A semi-quantitative assessment using model solvent mixtures supported method optimization and characterization of the target compounds. Quantitative validation was performed for the most frequently encountered residual solvents, demonstrating good selectivity, coefficients of determination (R2 = 0.981-0.998), low detection limits (0.07-0.29 mg L-1), satisfactory recoveries (70.2%-117.4%), and acceptable intra- and inter-day precision (RSD <15%). The proposed approach shows adequate performance for screening volatile residues in complex drug matrices such as cocaine hydrochloride. However, because the extraction strategy is based on saturated aqueous NaCl and does not require organic solvents, it can potentially be extended to other drug matrices that are soluble in aqueous media. This characteristic makes the approach particularly suitable for routine forensic applications. A kinetic study further revealed compound-dependent profiles, with rapid initial sorption followed by stabilization (e.g., aliphatics and ethers), whereas aromatics and several ketones showed a more progressive increase, indicating that equilibrium was not generally reached under the evaluated HS-SPME conditions.

PMID 43040781
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多antofloxacin hydrochloride